Family history and cardiovascular risk in familial hypercholesterolemia: Data in more than 1000 children

Circulation

Volumn 107, Issue 11, 2003, Pages 1473-1478

  Wiegman, Albert ^a   Rodenburg, Jessica ^a   De Jongh, Saskia ^a   Defesche, Joep C ^a   Bakker, Henk D ^a   Kastelein, John J P ^a,c   Sijbrands, Eric J G ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Department of Vascular Medicine ^*  (Netherlands)

Author keywords

Cardiovascular diseases; Cholesterol; Hypercholesterolemia; Lipoproteins

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; CHILD; COHORT ANALYSIS; DATA ANALYSIS; ENDOTHELIUM CELL; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; HETEROZYGOTE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR GENE; SURVIVAL;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DISEASE-FREE SURVIVAL; FAMILY HEALTH; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIFE STYLE; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; RISK FACTORS; ROC CURVE;

EID: 0037465809     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000058166.99182.54     Document Type: Article

References (27)

1. Lansberg PJ, Tuzgöl S, van de Ree MA, et al. Prevalence of familial hypercholesterolaemia in adults in four general practices in the Netherlands higher than expected. Ned Tijdschr Geneeskd. 2000;144:1437-1440.
2. Fouchier SW, Defesche JC, Umans-Eckenhausen MAW, et al. The molecular basis of familial hypercholesterolemia in The Netherlands. Hum Genet. 2001;109:602-615.
3. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
4. Stroes E, Kastelein JJP, Cosentino F, et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest. 1997;99:41-46.
5. Virkola K, Pesonen E, Åkerblom HK, et al. Cholesterol and carotid artery wall in children and adolescents with familial hypercholesterolemia: a controlled study by ultrasound. Acta Pediatr. 1997;86:1203-1207.
6. Wiegman A, Rodenburg J, Gort J, et al. B-mode ultrasound measurements of carotid artery walls in children with molecular proven familial hypercholesterolemia and their unaffected siblings. Circulation. 2001;104(suppl II):II-526. Abstract.
7. Tonstad S, Knudtzon J, Sivertsen M, et al. Efficacy and safety of cholesterylamine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr. 1996;129:42-49.
8. Stein EA, Illingworth DR, Kwiterovich PO Jr, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia. JAMA. 1999;281:137-144.
9. Sijbrands EJG, Westendorp RGJ, Lombardi MP, et al. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia. Atherosclerosis. 2000;149:421-425.
10. Sijbrands EJG, Westendorp RGJ, Defesche JC, et al. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ. 2001;322:1019-1023.
11. Fouchier SW, Defesche JC, Umans-Eckenhausen MAW, et al. The molecular basis of familial hypercholesterolemia in the Netherlands. Hum Genet. 2001;109:602-615.
12. Altman DB, Bland JM. Diagnostic tests 3 receiver operating characteristic plots. BMJ. 1994;309:188-189.
13. Kwiterovich PO Jr, Levy RI, Fredrickson DS. Neonatal diagnosis of familial type-II hyperlipoproteinaemia. Lancet. 1973;2:118-121.
14. Kwiterovich PO Jr, Fredrickson DS, Levy RI. Familial hypercholesterolaemia (one form of type II hyperlipoproteinaemia): a study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest. 1974;53:1237-1249.
15. Gillian-Daniel DL, Bates PW, Tebon A, et al. Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B. Proc Natl Acad Sci U S A. 2002;99:4337-4342.
16. Imazu A, Koizumi H, Kajinami K, et al. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. Horm Metab Res. 1992;24:284-288.
17. Frenais R, Ouguerram K, Maugeais C, et al. Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study. J Lipid Res. 1999;40:1506-1511.
18. Schaefer JR, Rader DJ, Idewaki K, et al. In vivo metabolism of apolipoprotein AI in a patient with homozygous familial hypercholesterolemia. Arterioscler Thromb. 1992;12:843-848.
19. Mastropaolo W, Matheny A Jr, Lang CA. Plasma cholesterol concentrations in twin children: estimates of genetic and environmental influences. Clin Chem. 2001;47:771.
20. Tonstad S, Leren TP, Sivertsen M, et al. Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler Thromb Vasc Biol. 1995;15:1009-1014.
21. Ohta T, Nakamura R, Ikeda Y, et al. Follow-up study on children with dyslipidemia detected by mass screening at 18 months of age: effect of 12 months dietary treatment. Eur J Pediatr. 1993;152:939-943.
22. National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89:525-584.
23. Glueck CJ, Mellies MJ, Dine M, et al. Safety and efficacy on long-term diet and diet plus bile acid binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia. Pediatrics. 1986;78:338-348.
24. Stein EA. Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis. 1989;9(suppl I):I-145-I-151.
25. Connor WE, Connor SL. Importance of diet in the treatment of familial hypercholesterolemia. Am J Cardiol. 1993;72:42D-53D.
26. Kwiterovich PO JR. Pediatric implications of heterozygous familial hypercholesterolemia: screening and dietary treatment. Arteriosclerosis. 1989;9(suppl I):I-111-I-120.
27. Leander K, Hallqvist J, Reuterwall C, et al. Family history of coronary heart disease, a strong risk factor for myocardial infarction interacting with other cardiovascular risk factors: results from the Stockholm Heart Epidemiology Program (SHEP). Epidemiology. 2001;12:215-221.